Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Michela Villa"'
Autor:
Luca Pace, Michela Villa, Roberta Massobrio, Margherita Giorgi, Daniela Attianese, Annamaria Ferrero
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology, Vol 50, Iss 5, p 105 (2023)
Objective: The potential of immunotherapy in gynaecological malignancies is being investigated in recent years. This review will discuss the current status of immunotherapy in endometrial (EC), ovarian (OC) and cervical (CC) cancers with particular a
Externí odkaz:
https://doaj.org/article/0fc445e5d4fb497d890cc5aa0e5935bc
Publikováno v:
Medicina, Vol 55, Iss 9, p 573 (2019)
Hormone replacement therapy (HRT) remains the most effective treatment for menopausal symptoms and has been shown to prevent bone loss and fracture. The progestogen is added to provide endometrial protection in women with an intact uterus. After the
Externí odkaz:
https://doaj.org/article/8a1d65ae714f49b2a1cc8a73aac30b8b
Publikováno v:
A: Pathogenic mechanisms.
Autor:
Annamaria Ferrero, Daniela Attianese, Margherita Giorgi, Roberta Massobrio, Michela Villa, Luca Pace
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology. 50:105
Autor:
Annamaria Ferrero, Giorgio Valabrega, M. Di Maio, U. De Giorgi, Gloria Mittica, Massimo Aglietta, L. Zavallone, Dionyssios Katsaros, A. Farolfi, Silvia Gemmiti, Fulvio Borella, E. Ghisoni, Michela Villa, Giulia Scotto, S. Mangiacotti, G. Giannone, Barbara Pasini, Margherita Turinetto, Valentina Tuninetti, Stefano Cosma
Publikováno v:
Gynecologic Oncology. 162:80-87
Background Hypersensitivity reactions (HSRs) to platinum are an important issue in the treatment of patients (pts) with ovarian cancer (OC). Germline BRCA mutations have been proposed as a risk factor. We aimed at evaluating the incidence and severit
Autor:
Annamaria Ferrero, Daniela Vassallo, Massimo Geuna, Luca Fuso, Michela Villa, Enrico Badellino, Martina Barboni, Paola Coata, Nathalie Santoro, Roberto C. Delgado Bolton, Nicoletta Biglia
Publikováno v:
Journal of gynecologic oncology. 33(6)
Malnutrition is frequent in ovarian cancer (OC) patients and may compromise post-operative outcomes. The aim of this study is to evaluate the impact of pre-operative immunonutrition on the surgical outcome of OC patients, and on their nutritional, in
Autor:
Giulia Parpinel, F Moro, A Ferrero, E Peirano, ME Laudani, Paolo Zola, M Barboni, L Fuso, Michela Villa
Publikováno v:
Ovarian cancer.
Introduction/Background* Incidence of ovarian cancer increases with age and reaches a peak at 70 years. The aim of the present study is the analysis of therapeutic differences, both surgical and pharmacological, in patients affected by ovarian cancer
Autor:
R Massobrio, Michela Villa, E Badellino, L Fuso, Nicoletta Biglia, M Bellero, Daniela Attianese, A Ferrero
Publikováno v:
Ovarian cancer.
Introduction/Background* Oral metronomic cyclophosphamide (OMC) consists in the chronic administration of low, usually daily, doses of chemotherapy. The effective reduction of tumor growth, oral administration, low toxicity profile and low cost make
Autor:
Nicoletta Biglia, Michela Villa, Daniela Attianese, Marco Bellero, Enrico Badellino, Roberta Massobrio, Annamaria Ferrero
Publikováno v:
Ovarian cancer.
Introduction/Background Oral metronomic cyclophosphamide (OMC) consists in the chronic administration of low, usually daily, doses of chemotherapy. The effective reduction of tumour growth, oral administration, low toxicity profile and low cost benef
Autor:
M Coppo, Borghese M, Daniela Attianese, Annamaria Ferrero, Nicoletta Biglia, Luca Fuso, Enrico Badellino, Michela Villa
Publikováno v:
Poster.
Objectives Aim of this prospective study is the development and clinical application of a tool to identify frailty in patients > 70 years old affected by either ovarian or endometrial cancer. After identifying a cut off to establish frailty, differen